What drives ALNA stock volatility?

ALNA stock volatility stems from microcap liquidity, clinical-stage binary events for ALLN-346, retail-driven volume spikes, and thin order books. Any trial update or partnering news can cause rapid price swings.

What is the Meyka AI outlook for ALNA stock?

Meyka AI projects **$0.12** in 12 months for ALNA stock, an implied **60.00%** upside from **$0.075**. Forecasts are model-based projections and not guarantees.

Are fundamentals supportive of ALNA stock long term?

Fundamentals show negative EPS (**-0.64**) and negative operating cash flow per share (**-1.41**), but cash per share (**$0.92**) and current ratio (**2.11**) provide short-term runway. Long-term value depends on clinical and licensing outcomes.

How should traders approach ALNA stock in the pre-market?

In pre-market, use smaller size, confirm liquidity on the open, and set stop losses. Heavy pre-market volume can reverse after market open due to thin early liquidity.

US Stocks

ALNA stock $0.075 pre-market on 252,311,606 volume 17 Feb 2026: watch catalysts

ByDanny Kontos February 17, 2026February 17, 2026

ALNA stock is trading at $0.075 pre-market on 252,311,606 shares, making Allena Pharmaceuticals (ALNA) one of the most active names on NASDAQ in the pre-market session on 17 Feb 2026. The spike in volume has lifted intraday range to a day low $0.06 and day high $0.1459, after an open at $0.0641 and a prior close of $0.0727. Traders are responding to clinical-stage biotech dynamics; we examine fundamentals, valuation, and short-term catalysts in this most-active equity update for the United States market.